These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 20832579)

  • 41. Hematopoietic stem cell transplantation for childhood myeloid malignancies after high-dose thiotepa, busulfan and cyclophosphamide.
    Worth L; Tran H; Petropoulos D; Culbert S; Mullen C; Roberts W; Przepiorka D; Chan K
    Bone Marrow Transplant; 1999 Nov; 24(9):947-52. PubMed ID: 10556952
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prospective phase II trial to evaluate the complications and kinetics of chimerism induction following allogeneic hematopoietic stem cell transplantation with fludarabine and busulfan.
    Saito AM; Kami M; Mori S; Kanda Y; Suzuki R; Mineishi S; Takami A; Taniguchi S; Takemoto Y; Hara M; Yamaguchi M; Hino M; Yoshida T; Kim SW; Hori A; Ohashi Y; Takaue Y
    Am J Hematol; 2007 Oct; 82(10):873-80. PubMed ID: 17570513
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
    Kröger N; Bornhäuser M; Ehninger G; Schwerdtfeger R; Biersack H; Sayer HG; Wandt H; Schäfer-Eckardt K; Beyer J; Kiehl M; Zander AR;
    Ann Hematol; 2003 Jun; 82(6):336-42. PubMed ID: 12728337
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lymphocyte reconstitution following allogeneic hematopoietic stem cell transplantation: a retrospective study including 148 patients.
    Heining C; Spyridonidis A; Bernhardt E; Schulte-Mönting J; Behringer D; Grüllich C; Jakob A; Bertz H; Finke J
    Bone Marrow Transplant; 2007 May; 39(10):613-22. PubMed ID: 17384658
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Continuous bladder irrigation prevents hemorrhagic cystitis after allogeneic hematopoietic cell transplantation.
    Hadjibabaie M; Alimoghaddam K; Shamshiri AR; Iravani M; Bahar B; Mousavi A; Jahani M; Khodabandeh A; Anvari Y; Gholami K; Ghavamzadeh A
    Urol Oncol; 2008; 26(1):43-6. PubMed ID: 18190829
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of readmissions in hematopoietic stem cell transplant recipients.
    Moya R; Espigado I; Parody R; Carmona M; Márquez F; De Blas JM
    Transplant Proc; 2006 Oct; 38(8):2591-2. PubMed ID: 17098011
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group.
    Schetelig J; Thiede C; Bornhauser M; Schwerdtfeger R; Kiehl M; Beyer J; Sayer HG; Kroger N; Hensel M; Scheffold C; Held TK; Hoffken K; Ho AD; Kienast J; Neubauer A; Zander AR; Fauser AA; Ehninger G; Siegert W;
    J Clin Oncol; 2003 Jul; 21(14):2747-53. PubMed ID: 12860954
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neurological manifestation of CMV disease after allogeneic haematopoietic stem cells transplantation--a case report.
    Zaucha-Prazmo A; Wójcik B; Drabko K; Choma M; Kowalczyk JR
    Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):198-200. PubMed ID: 16146077
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Allogeneic HSCT for autoimmune diseases: conventional conditioning regimens.
    Nash RA
    Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S77-80. PubMed ID: 12931249
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Syndrome inappropriate ADH secretion after allogeneic hematopoietic stem cell transplantation: a case report and literature review].
    Jiang Q; Liu KY; Huang XJ; Lu WK
    Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):78-81. PubMed ID: 16732956
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Secondary failure of platelet recovery after hematopoietic stem cell transplantation.
    Bruno B; Gooley T; Sullivan KM; Davis C; Bensinger WI; Storb R; Nash RA
    Biol Blood Marrow Transplant; 2001; 7(3):154-62. PubMed ID: 11302549
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndrome.
    Alyea EP; Kim HT; Ho V; Cutler C; DeAngelo DJ; Stone R; Ritz J; Antin JH; Soiffer RJ
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1047-55. PubMed ID: 17067911
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Optimizing management of myelodysplastic syndromes post-allogeneic transplantation.
    Sockel K; Ehninger G; Hofbauer LC; Platzbecker U
    Expert Rev Hematol; 2011 Dec; 4(6):669-80. PubMed ID: 22077530
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Physical activity for patients undergoing an allogeneic hematopoietic stem cell transplantation: benefits of a moderate exercise intervention.
    Baumann FT; Zopf EM; Nykamp E; Kraut L; Schüle K; Elter T; Fauser AA; Bloch W
    Eur J Haematol; 2011 Aug; 87(2):148-56. PubMed ID: 21545527
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Allogeneic stem cell transplantation for aplastic anemia.
    Armand P; Antin JH
    Biol Blood Marrow Transplant; 2007 May; 13(5):505-16. PubMed ID: 17448909
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Second allogeneic stem cell transplantation in a patient with hypoplastic myelodysplastic syndrome following a primary diagnosis of aplastic anaemia.
    Ocheni S; Oyekunle A; Kröger N; Ayuk F; Klyuchnikov E; Arps S; Held K; Zabelina T; Adjallé R; Wolschke C; Zander AR; Bacher U
    Acta Haematol; 2011; 125(3):175-8. PubMed ID: 21196720
    [No Abstract]   [Full Text] [Related]  

  • 57. Immune reconstitution: the foundation for safe living after an allogeneic hematopoietic stem cell transplantation.
    Laffan A; Biedrzycki B
    Clin J Oncol Nurs; 2006 Dec; 10(6):787-94. PubMed ID: 17193944
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Indication and results of hematopoietic stem cell transplantation. 3. Aplastic anemia and myelodysplastic syndrome].
    Sakamaki H
    Nihon Naika Gakkai Zasshi; 1998 Aug; 87(8):1477-82. PubMed ID: 9780674
    [No Abstract]   [Full Text] [Related]  

  • 59. Disseminated Rhizomucor pusillus causing early multiorgan failure during hematopoietic stem cell transplantation for severe aplastic anemia.
    Rawlinson NJ; Fung B; Gross TG; Termuhlen AM; Skeens M; Garee A; Soni S; Pietryga D; Bajwa RP
    J Pediatr Hematol Oncol; 2011 Apr; 33(3):235-7. PubMed ID: 21358340
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recombinant Human Thrombopoietin Promotes Platelet Engraftment and Improves Prognosis of Patients with Myelodysplastic Syndromes and Aplastic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation.
    Wang H; Huang M; Zhao Y; Qi JQ; Chen C; Tang YQ; Qiu HY; Fu CC; Tang XW; Wu DP; Ruan CG; Han Y
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1678-1684. PubMed ID: 28642072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.